Skip to main content
Clinical Trials/NCT03637348
NCT03637348CompletedNot Applicable

Effect of TrueTear Use on Anterior Corneal Surface Imaging Quality

Price Vision Group1 site in 1 country45 target enrollmentStarted: August 13, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
45
Locations
1
Primary Endpoint
Surface Asymmetry Index (SAI) Assessed With Corneal Topography

Study Overview

Brief Summary

This study will evaluate the utility of TrueTear™ to improve anterior corneal surface imaging quality before cataract surgery, refractive lens exchange, or laser refractive surgery.

Detailed Description

Corneal imaging will be repeated before and after TrueTear use during a single patient visit. Image quality measures will be compared.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Scheduled to undergo routine imaging for cataract surgery, refractive lens exchange or laser refractive surgery

Exclusion Criteria

  • •A cardiac pacemaker, implanted or wearable defibrillator, or other implanted metallic or electronic device (e.g. cochlear implant) in the head or neck
  • •Chronic or frequent nosebleeds, a bleeding disorder (e.g. hemophilia), or another condition that can lead to increased bleeding
  • •A known hypersensitivity (allergy) to the hydrogel material that comes into contact with the inside of the nose during use of the TrueTearTM device
  • •Pregnancy
  • •Presence of any ocular disease or condition which in the investigator's opinion would confound the study results

Arms & Interventions

TrueTear

Other

Use of TrueTear device to stimulate tear production

Intervention: TrueTear (Device)

Outcomes

Primary Outcomes

Surface Asymmetry Index (SAI) Assessed With Corneal Topography

Time Frame: Change from baseline SAI at 5-10 minutes after using the TrueTear device.

Surface asymmetry index (SAI) is an index that indicates an average value of the corneal power differences between the points spatially located at 180° from 128 equidistant meridians. A radially symmetrical surface has a value of zero, and this value increases as the degree of asymmetry is greater. Higher values are worse, but there is no set maximum value and no unit of measure.

Secondary Outcomes

  • Surface Regularity Index (SRI) Assessed With Corneal Topography(Change from baseline SRI at 5-10 minutes after using the TrueTear device.)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials